Sale!

Parainfluenza 1-2-3-4 Multiplex Detection & Differentiation Quantitative Test

Original price was: $340.Current price is: $290.

-15%

The Parainfluenza 1-2-3-4 Multiplex Detection & Differentiation Quantitative Test is an advanced molecular diagnostic tool that simultaneously detects and differentiates between all four types of human parainfluenza viruses using Real Time RT-PCR technology. This comprehensive test provides precise identification of HPIV-1, HPIV-2, HPIV-3, and HPIV-4 infections, enabling healthcare providers to make informed treatment decisions for respiratory illnesses. The test is particularly valuable for patients experiencing respiratory symptoms, immunocompromised individuals, and those requiring accurate viral diagnosis for appropriate medical management. Results are typically available within 36-48 hours, with a discounted price of $290 USD and regular price of $340 USD.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Parainfluenza 1-2-3-4 Multiplex Detection & Differentiation Quantitative Test

Comprehensive Respiratory Virus Detection

The Parainfluenza 1-2-3-4 Multiplex Detection & Differentiation Quantitative Test represents a cutting-edge molecular diagnostic solution for identifying and distinguishing between all four types of human parainfluenza viruses (HPIV). This advanced Real Time RT-PCR based test provides healthcare professionals with precise, quantitative data essential for accurate diagnosis and effective treatment planning of respiratory infections.

What This Test Measures and Detects

This sophisticated multiplex assay simultaneously identifies and differentiates:

  • Human Parainfluenza Virus Type 1 (HPIV-1)
  • Human Parainfluenza Virus Type 2 (HPIV-2)
  • Human Parainfluenza Virus Type 3 (HPIV-3)
  • Human Parainfluenza Virus Type 4 (HPIV-4)

The quantitative nature of this test provides viral load measurements, offering valuable insights into infection severity and progression. Using state-of-the-art Real Time Reverse Transcription Polymerase Chain Reaction technology, this test delivers exceptional sensitivity and specificity in detecting parainfluenza viral RNA.

Who Should Consider This Test

This comprehensive diagnostic test is recommended for individuals experiencing:

  • Persistent respiratory symptoms including cough, congestion, and breathing difficulties
  • Suspected viral respiratory infections with unclear etiology
  • Severe respiratory illness requiring hospitalization
  • Immunocompromised patients with respiratory symptoms
  • Children with croup-like symptoms or bronchiolitis
  • Patients with recurrent respiratory infections
  • Individuals in high-risk environments such as healthcare facilities or crowded living conditions

Clinical Benefits of Parainfluenza Testing

Choosing the Parainfluenza 1-2-3-4 Multiplex Detection & Differentiation Quantitative Test offers numerous advantages:

  • Accurate Diagnosis: Precise identification of specific parainfluenza virus types enables targeted treatment approaches
  • Rapid Results: Quick turnaround time of 36-48 hours facilitates timely medical interventions
  • Comprehensive Coverage: Simultaneous detection of all four parainfluenza virus types eliminates the need for multiple tests
  • Quantitative Data: Viral load measurements provide insights into infection severity and treatment response
  • Infection Control: Early identification helps implement appropriate isolation measures in healthcare settings
  • Treatment Guidance: Specific virus identification informs antiviral therapy decisions when applicable

Understanding Your Test Results

Your test results will provide clear information about parainfluenza virus detection:

  • Positive Result: Indicates active infection with one or more parainfluenza virus types, with specific identification of which types are present
  • Negative Result: Suggests absence of detectable parainfluenza viruses in the tested sample
  • Viral Load Quantification: Provides numerical values indicating the amount of virus present, which can help assess infection severity
  • Type Differentiation: Clearly identifies which specific parainfluenza types (1, 2, 3, or 4) are detected

Your healthcare provider will interpret these results in the context of your symptoms, medical history, and clinical presentation to determine the most appropriate treatment plan.

Test Pricing Information

Price Type Amount (USD)
Discount Price $290
Regular Price $340

Nationwide Testing Availability

GGC DNA maintains testing facilities across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible, reliable testing services for patients throughout the country.

Take Action for Your Respiratory Health

Don’t let respiratory symptoms go undiagnosed. The Parainfluenza 1-2-3-4 Multiplex Detection & Differentiation Quantitative Test provides the comprehensive information needed for accurate diagnosis and effective treatment. Contact us today to schedule your test and take the first step toward better respiratory health.

Book Your Test Today: Call or WhatsApp +1(267) 388-9828 to schedule your appointment or get more information about our comprehensive parainfluenza testing services.